Results presented here, together with previous observations obtained by other groups 45 indicate that enhanced ligand-triggered ALK stimulation rather than genetic alterations on this receptor would be responsible for the effects observed in GICs and therefore in GBM biology. The gene discussed is ALK; the disease is glioblastoma.